Pacira | PCRX - Despesas De Vendas E Administração





Despesas De Vendas E Administração Alterar Data
Assertio Holdings USD 16.73M 1.66M 2024-09
Astellas Pharma JPY 234.7B 12.92B 2026-03
Bristol-Myers Squibb USD 1.62B 564M 2026-03
Cara Therapeutics USD 2.19M 2.45M 2025-09
Coherus Biosciences USD 15M 6.26M 2025-12
Heron Therapeutics USD 23.74M 605K 2025-12
Ironwood Pharmaceuticals USD 33.33M 2.78M 2024-12
J&J USD 6.03B 719M 2026-03
Ligand Pharmaceuticals USD 28.45M 8.27M 2025-09
Nektar Therapeutics USD 10.17M 10.17M 2025-12
Novo Nordisk DKK 17.44B 1.41B 2025-12
Omeros USD 11.32M 2.48M 2024-09
Pacira USD 83.88M 7.99M 2026-03
Perrigo USD 255.9M 10.2M 2025-12
Pfizer USD 2.92B 1.16B 2026-03
Supernus Pharmaceuticals USD 118.23M 4.16M 2026-03
Teva Pharmaceutical Industries USD 1000M 120M 2026-03
Xeris Pharmaceuticals USD 42.64M 3.82M 2025-12
Xoma USD 11M 2.54M 2024-06
Zoetis USD 619M 40M 2025-12